Advertisement
Advertisement
Trending on Urology Times
1
ORIC-944 shows promise in combination with ARPIs for mCRPC
2
Radioligands and ADT alternatives emerge in prostate cancer treatment
3
Jason Hafron, MD, recaps prostate cancer data from ESMO 2025
4
Beyond PSA: Jonathan Henderson, MD, on precision tools for prostate cancer
5
